Tatiana Koudriavtseva

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Relapsing-Remitting Multiple Sclerosis 69%
3. perampanel 25%
4. Interferons 23%
5. Glioma 19%
6. Interferon beta-1a 18%
7. Magnetic Resonance Imaging 17%
8. Recurrence 17%
9. Therapeutics 16%
10. Silver Sulfadiazine 14%
11. Gadolinium 14%
12. Brain Neoplasms 13%
13. Interferon-beta 12%
14. Epilepsy 12%
15. Diabetic Foot 11%
16. Autoimmune Experimental Encephalomyelitis 11%
17. Bevacizumab 11%
18. Steroids 10%
19. Biofilms 9%
20. Seizures 9%
21. Pseudomonas aeruginosa 9%
22. Observational Studies 9%
23. Multicenter Studies 8%
24. Staphylococcus aureus 8%
25. Gadolinium DTPA 8%
26. Thrombin 7%
27. Lymphocyte Subsets 7%
28. Leber's Hereditary Optic Atrophy 7%
29. Natalizumab 7%
30. Sequence Inversion 7%
31. Cerebral Amyloid Angiopathy 7%
32. Herpes Simplex Encephalitis 7%
33. Neuromyelitis Optica 6%
34. Hydroxychloroquine 6%
35. Physician-Patient Relations 6%
36. Annexins 6%
37. Anti-Bacterial Agents 6%
38. Limbic System 6%
39. Antiphospholipid Antibodies 6%
40. Antithrombins 6%
41. Brain 6%
42. estropipate 5%
43. Art 5%
44. Chloroquine 5%
45. Carboplatin 5%
46. gadoteridol 5%
47. Radiotherapy 5%
48. Lymphocytes 5%
49. von Willebrand Factor 5%
50. Public Hospitals 5%